Lilly Ventures pumps funds into startup

November 2, 2007
HemaQuest Pharmaceuticals, a startup in Newton, Mass., said today it has received $20 million in funding from Lilly Ventures, De Novo Ventures of Palo Alto, Calif.; and Forward Ventures of San Diego.

The amount of the investment by Lilly Ventures, the venture capital arm of Indianapolis-based Eli Lilly and Co., wasn't specified.

HemaQuest is developing small molecule therapies to treat sickle cell anemia and other blood disorders.
Source: XMLFULL/XMLFull7155.xml

Recent Articles by IBJ Staff

Comments powered by Disqus